Details of Epigenetic Molecule(EM)
General Information of EM (ID: EM12005) | |||||||
---|---|---|---|---|---|---|---|
Official Symbol |
CSGALNACT2
|
||||||
Official Full Name |
Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2
|
||||||
Synonym |
Chondroitin Sulfate N-Acetylgalactosaminyltransferase 2;GALNACT2;GALNACT-2;PRO0082;Glucuronylgalactosylproteoglycan 4-Beta-N-Acetylgalactosaminyltransferase 2;Chondroitin Beta1,4 N-Acetylgalactosaminyltransferase 2;MGC40204;Beta4GalNAcT-2;Beta4GalNAcT;Chondroitin Beta-1,4-N-Acetylgalactosaminyltransferase 2
|
||||||
Molecule Type |
Protein coding
|
||||||
Position On Chromosome |
chr10(Start:43138445 - End:43185308)
|
||||||
Strand |
+
|
||||||
Uniprot Entry | |||||||
ENSG ID | |||||||
Disease Relevance (Click to Show/Hide) | |||||||
2C30: Melanoma of skin | Cutaneous Melanoma [Melanoma of skin] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
5A02: Thyrotoxicosis | Graves' disease [Thyrotoxicosis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A01: Choreiform disorders | Huntington's disease (HD) [Choreiform disorders] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
8A20: Alzheimer disease | Alzheimer's disease [Alzheimer disease] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
CB03: Idiopathic interstitial pneumonitis | Idiopathic pulmonary fibrosis (IPF) [Idiopathic interstitial pneumonitis] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
LD2C: Overgrowth syndromes | Sotos syndrome(SS) [Overgrowth syndromes] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
SE30: Developmental delay disorder | CHARGE and Kabuki syndromes [Developmental delay disorder] | ||||||
Detailed Information |
Disease Link
![]() |
||||||
XH4KA9: Burkitt lymphoma | Burkitt Lymphoma [Burkitt lymphoma] | ||||||
Detailed Information |
Disease Link
![]() |
Metabolite(s) with this epigenetic modification | |||||||
---|---|---|---|---|---|---|---|
Metabolite Name: Valerate | |||||||
Detailed Information |
Meta Info
![]() |
[1], [2] | |||||
Description |
Valerate has been shown to hypermethylate CSGALNACT2 CpG site in breast cancer cells.
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.